M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid Tumors
Clinical trial NCT07166601 · RECRUITING
Trial details
- NCT number
- NCT07166601
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-10
- Primary completion
- 2029-02-23
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.